Loading insider details...
Beta
Latest Form 4 (Apr 17, 2026): Grant/Award of 800,000 ALXO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 17, 2026 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 800,000 | n/a |
| Apr 10, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 49,474 | $1.19M |
| Mar 18, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 5,950 | $220.8K |
| Feb 25, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 34,000 | n/a |
| Mar 21, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 6,801 | $232.4K |
| Feb 24, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 43,000 | n/a |
| Nov 26, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 501 | $28.3K |
| Jul 17, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 17,499 | $419.6K |
| Jun 28, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 956 | $42.4K |
| Mar 26, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 30,000 | $719.4K |